Fiji vs Oman: The number of people with susceptibility test result for rifampicin
Fiji
127
in 2021
Oman
144
in 2021
Fiji rank
105th
Oman rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Fiji
- Oman
How they compare
Oman currently reports 144 against 127 in Fiji, a difference of 17.
That makes Oman's figure about 1.1 times Fiji's.
Across all 5 years both countries report, Oman has been ahead every year.
Fiji ranks 105th and Oman ranks 102nd of 155 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 139 | 220.67 | 81.67 | Oman |
| 2020s | 123.5 | 181 | 57.5 | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Fiji or Oman?
- Oman, at 144 against 127 in Fiji as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Fiji and Oman?
- 17, with Oman ahead.
- How many years of comparable data are there for Fiji and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Fiji and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Fiji ranks 105th and Oman ranks 102nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.